Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.361
Sell
RSI(14)
38.701
Neutral
STOCH(KDJ)(9,3,3)
25.178
Neutral
ATR(14)
1.540
High Vlolatility
CCI(14)
-123.728
Sell
Williams %R
68.622
Sell
TRIX(12,20)
-0.551
Sell
StochRSI(14)
49.850
Buy
Bruker Corp
BRKR30.830USD
+1.040+3.49%
Close 09/05, 16:00（ET）Quotes delayed by 15 min
4.68BMarket Cap
58.76P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-05Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
15
analysts
Buy
Current Rating
44.862
Target Price
+45.51%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. Its product lines include nCounter, CosMx, GeoMx and AtoMx. It also owns electron paramagnetic resonance (EPR) business.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.02% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 26.70%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 26.70%.
Overvalued
The company’s latest PE is 58.82, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 171.75M shares, decreasing 4.00% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 10.40M shares of this stock.
Financial Health
Currency: USD Updated：2025-09-05The company's current financial score is 8.05, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 801.40M, representing a year-over-year increase of 11.04%, while its net profit experienced a year-over-year increase of 65.82%.
Score
Financials
6.73
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
9.62
Operational Efficiency
7.53
Growth Potential
7.33
Shareholder Returns
9.03
Company Valuation
Currency: USD Updated：2025-09-05The company’s current valuation score is 4.80, which is higher than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 64.09, which is -42.63% below the recent high of 36.77 and 55.19% above the recent low of 28.72.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 49/280
No Data
Earnings Forecast
Currency: USD Updated：2025-09-05The company’s current earnings forecast score is 7.33, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Bruker Corp is 43.00, with a high of 65.00 and a low of 30.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
15
analysts
Buy
Current Rating
44.862
Target Price
+45.51%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Bruker Corp
BRKR
15
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-05The company’s current price momentum score is 7.00, which is lower than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 40.05 and the support level at 28.56, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
31.436
Sell
MA10
32.844
Sell
MA20
33.016
Sell
MA50
37.270
Sell
MA100
37.838
Sell
MA200
45.125
Sell
Institutional Confidence
Currency: USD Updated：2025-09-05The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 113.23%, representing a quarter-over-quarter decrease of 1.11%. The largest institutional shareholder is The Vanguard, holding a total of 10.40M shares, representing 6.86% of shares outstanding, with 2.18% decrease in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
Laukien (Frank H)
T. Rowe Price Investment Management, Inc.
Pallas Capital Advisors LLC
BlackRock Institutional Trust Company, N.A.
Laukien (Joerg C)
Fidelity Management & Research Company LLC
The London Company of Virginia, LLC
State Street Global Advisors (US)
1
2
Risk Assessment
Currency: USD Updated：2025-09-05The company's beta value is 1.22. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.22
VaR
+3.85%
240-Day Maximum Drawdown
+58.47%
240-Day Volatility
+53.07%
Return
Best Daily Return
60 days
+8.88%
120 days
+13.28%
5 years
+13.28%
Worst Daily Return
60 days
-12.12%
120 days
-12.12%
5 years
-12.12%
Sharpe Ratio
60 days
-1.27
120 days
-1.01
5 years
-0.08
Risk Assessment
Maximum Drawdown
240 days
+58.47%
3 years
+68.87%
5 years
+68.87%
Return-to-Drawdown Ratio
240 days
-0.94
3 years
-0.22
5 years
-0.12
Skewness
240 days
-0.01
3 years
-0.10
5 years
-0.11
Volatility
Realised Volatility
240 days
+53.07%
5 years
+40.86%
Standardised True Range
240 days
+6.86%
5 years
+6.93%
Downside Risk-Adjusted Return
120 days
-138.67%
240 days
-138.67%
Maximum Daily Upside Volatility
60 days
+48.02%
Maximum Daily Downside Volatility
60 days
+53.76%
Liquidity
Average Turnover Rate
60 days
+1.96%
120 days
+1.78%
5 years
--
Turnover Deviation
20 days
+106.54%
60 days
+91.77%
120 days
+74.64%
Peer Comparison
Currency: USD Updated：2025-09-05Bruker Corp
BRKR
6.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
